Deprecated: mysql_connect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/strxon5/public_html/config.php on line 6
Xybrin (320,000 FU Systemic Enzyme)
You have Pulmonary Fibrosis.

Product Detail Page

Xybrin (320,000 FU Systemic Enzyme)

Xybrin (320,000 FU Systemic Enzyme)

Sale Price: $124.99

Delivery One time Only

Add to Set and Save

Xybrin (Zye-brin)

Xybrin is an Extracellular Systemic Enzyme that combines the powerful fibrin reducing enzymes Serrapeptase, Nattokinase and Lumbrokinase, accompanied by Bromelain, Protease, Lipase and Organic Amla to create the worlds most effictive systemic enzyme blend. Xybrin is formulated specifically to remove fibrin in the body. Xybrin accomplishes this by cleaving or cutting the fibrin from healthy tissue and utilizing removal processes such as urine and feces to rid the body of fibrin. To enhance the effectiveness, Xybrin has been enterically coated to ensure passage of the stomach stomach acid for absorption where it reaches the less acidic small intestine (where most nutrient absorption takes place). Enteric coating allows these sensitive enzymes to survive the acidic conditions of the stomach, allowing them to pass into the circulatory system while maintaining high (FU) activity levels. Enzyme activity is measured in fibrinolytic units (FU). Tests have shown that Serrapeptase, Lumbrokinase and Nattokinase lose significant activity when exposed to acidic conditions, such as those in the stomach, which is why it is imperative that your systemic enzyme is enterically coated like Xybrin, so that you get the most fibrinolytic activity possible. Xybrin has the highest amount of FU's of any systemic enzyme in the world (320,000FU's).

What makes Xybrin?

Serrapeptase: Serrapeptase digests inflammations, scars tissue, fibrin, blood clots, cysts, non-benign tumors, arterial plaques and inflammation in all forms. Since Serrapeptase has shown to have a significant impact on the removal of fibrin (scar tissue), ERP’s (erogenous blood particles), and toxin and debris from the bloodstream, Serrapeptase was an obvious choice for building Xybrin around.

Nattokinase: Nattokinase is a highly fibrinolytic (fibrin-dissolving) enzyme. As we age, fibrinolysis is impaired and fibrin begins to accumulate in the body. Firstly, nattokinase is a naturally fibrinolytic enzyme, which means that it works to keep the body at normal amounts of fibrin by removing excess. Nattokinase is actually 4-times more potent than the body's own natural fibrin defense mechanisms.

Lumbrokinase: Lumbrokinase is the newest enzyme which shows significant promise in dissolving fibrin and blood clots due to its uniquely high affinity for fibrin. Clinical studies have shown that stroke patients on Lumbrokinase within one month following a stroke showed almost complete recovery. Studies have also shown that Lumbrokinase has significant efficacy in removing fibrin in conditions like Pulmonary Fibrosis, Uterine Fibroids and Peyronie's Disease.

The Xybrin difference

It has been over 10 years since any significant formula changes were made to the systemic enzyme market, until now. Unlike many of it's predecessors, Xybrin was developed with 2 things in mind, 1) To be the most powerful fibrin reducing enzyme in the world, and 2) to make it easier to take by reducing the capsule count to 3 per day. This sort of revolution hasn't been seen in enzyme products since the early 2000's. With over 20 years of Medical experience Orion Medical Group has brought a game changing new formula to the people who suffer from Pulmonary Fibrosis...Xybrin. By combining high doses of 3 proven fibrin reducing enzymes in perfectly blended quantities, Xybrin has separated itself from the competition making it the #1 choice for people suffering from Pulmonary Fibrosis. 

Please read: Serrapeptase does thin the blood by removing toxins and debris naturally. Do not take Xybrin if you are currently taking any blood thinning medication (Coumadin, Warfarin, etc.), without consulting your doctor prior.